Is Eli Lilly Stock a No-Brainer Buy After the Company’s Brilliant Zepbound Move?
The Motley FoolSome insurers don’t cover Lilly’s obesity drug. The company just gave patients a way around that problem.
Some insurers don’t cover Lilly’s obesity drug. The company just gave patients a way around that problem.